RYDEX SERIES FUNDS's S&P MidCap 400 Pure Growth Fund (RYBHX) has disclosed 91 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2025-03-31. The current portfolio value is calculated to be $25.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 6%.
S&P MidCap 400 Pure Growth Fund (RYBHX)'s
Total Assets is $25.23 Mil , Total Liabilities is $65,170.00 , Net Assets is $25.17 Mil.
In S&P MidCap 400 Pure Growth Fund (RYBHX)'s current portfolio as of 2025-03-31, the top 5 holdings are
Roivant Sciences Ltd (ROIV), Carpenter Technology Corp (CRS), Valaris Ltd (VAL), Globus Medical Inc (GMED) and Hims & Hers Health Inc (HIMS),
not including call and put options.
S&P MidCap 400 Pure Growth Fund (RYBHX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for S&P MidCap 400 Pure Growth Fund (RYBHX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for S&P MidCap 400 Pure Growth Fund (RYBHX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for S&P MidCap 400 Pure Growth Fund.